These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2515243)

  • 1. Early cell envelope alterations by tobramycin associated with its lethal action on Pseudomonas aeruginosa.
    Raulston JE; Montie TC
    J Gen Microbiol; 1989 Nov; 135(11):3023-34. PubMed ID: 2515243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.
    Gilleland LB; Gilleland HE; Gibson JA; Champlin FR
    J Med Microbiol; 1989 May; 29(1):41-50. PubMed ID: 2498520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
    Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
    Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of aminoglycoside resistance in variants of Pseudomonas aeruginosa isolated during treatment of experimental endocarditis in rabbits.
    Parr TR; Bayer AS
    J Infect Dis; 1988 Nov; 158(5):1003-10. PubMed ID: 3141520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
    Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.
    Nickel JC; Ruseska I; Wright JB; Costerton JW
    Antimicrob Agents Chemother; 1985 Apr; 27(4):619-24. PubMed ID: 3923925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface action of gentamicin on Pseudomonas aeruginosa.
    Kadurugamuwa JL; Clarke AJ; Beveridge TJ
    J Bacteriol; 1993 Sep; 175(18):5798-805. PubMed ID: 8376327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes.
    Alipour M; Suntres ZE; Lafrenie RM; Omri A
    J Antimicrob Chemother; 2010 Apr; 65(4):684-93. PubMed ID: 20159770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa.
    Nichols WW; Evans MJ; Slack MP; Walmsley HL
    J Gen Microbiol; 1989 May; 135(5):1291-303. PubMed ID: 2516117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
    Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.
    Werneburg M; Zerbe K; Juhas M; Bigler L; Stalder U; Kaech A; Ziegler U; Obrecht D; Eberl L; Robinson JA
    Chembiochem; 2012 Aug; 13(12):1767-75. PubMed ID: 22807320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
    MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
    J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
    Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O; Giwercman B; Pedersen SS; Høiby N
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Treerat P; Widmer F; Middleton PG; Iredell J; George AM
    FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa.
    Lagacé J; Dubreuil M; Montplaisir S
    J Microencapsul; 1991; 8(1):53-61. PubMed ID: 1908898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Andrés MT; Viejo-Diaz M; Pérez F; Fierro JF
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1613-6. PubMed ID: 15793153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.